Inter-Tumor Heterogeneity—Melanomas Respond Differently to GM-CSF-Mediated Activation
Granulocyte-monocyte colony stimulating factor (GM-CSF) is used as an adjuvant in various clinical and preclinical studies with contradictory results. These were attributed to opposing effects of GM-CSF on the immune or myeloid systems of the treated patients or to lack of optimal dosing regimens. T...
Main Authors: | Adi Moshe, Sivan Izraely, Orit Sagi-Assif, Sapir Malka, Shlomit Ben-Menachem, Tsipi Meshel, Metsada Pasmanik-Chor, Dave S.B. Hoon, Isaac P. Witz |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/9/7/1683 |
Similar Items
-
Whole tumor cell vaccines engineered to secrete GM‐CSF (GVAX)
by: Robert J. Soiffer, et al.
Published: (2021-06-01) -
GM-CSF: A Promising Target in Inflammation and Autoimmunity
by: Lee KMC, et al.
Published: (2020-10-01) -
The Vicious Cycle of Melanoma-Microglia Crosstalk: Inter-Melanoma Variations in the Brain-Metastasis-Promoting IL-6/JAK/STAT3 Signaling Pathway
by: Sivan Izraely, et al.
Published: (2023-05-01) -
Use of rhu-GM-CSF in pulmonary tuberculosis patients: results of a randomized clinical trial
by: Diana Brasil Pedral-Sampaio, et al. -
DOSE-DEPENDENT EFFECTS OF ANTIBACTERIAL ACTIVITY OF SYNTHETIC PEPTIDES ISOLATED FROM GM-CSF ACTIVE CENTER
by: A. V. Zurochka, et al.
Published: (2014-07-01)